CytoSorbents（CTSO.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

股东类型

公众及其他59.71%
机构投资者25.62%
个人与内部人士14.67%

主要股东

主要股东最新
股东
Avenir Corporation	8.23%	25.95 万	0.08%	-1,328.00	2026/06/30
Mary Ley	7.27%	22.91 万	0.87%	+2.83 万	2026/06/01
Vanguard Capital Management, LLC	3.54%	11.15 万	0.04%	+1,819.00	2026/06/30
Neuberger Berman Investment Advisers LLC	3.12%	9.84 万	0.44%	+1.43 万	2026/06/30
Thomas Satterfield	2.86%	9.03 万	0.01%	+0	2025/01/13
Phillip ChanCEO & Director	2.66%	8.38 万	0.39%	+1.26 万	2026/09/15
CM Management, LLC	2.34%	7.38 万	0.01%	+0	2026/06/30
Skylands Capital, LLC	1.92%	6.06 万	0.80%	-2.48 万	2026/06/30
BlackRock, Inc.	1.00%	3.14 万	0.25%	-7,789.00	2026/06/30
Geode Capital Management, LLC	0.96%	3.01 万	0.17%	-5,261.00	2026/06/30
Sargent Investment Group, LLC	0.88%	2.78 万	<0.01%	+292.00	2026/06/30
Vincent CapponiPresident & COO	0.82%	2.57 万	0.13%	+4,253.00	2026/09/14
Pathstone Family Office, LLC	0.79%	2.50 万	<0.01%	-2.00	2026/06/30
Peter MarianiChief Financial Officer	0.34%	1.08 万	0.16%	+5,000.00	2026/06/15
Efthymios DeliargyrisChief Medical Officer	0.31%	9,876.00	<0.01%	+0	2026/06/01
CIBC Private Wealth Advisors, Inc.	0.27%	8,632.00	<0.01%	+0	2026/06/30
State Street Investment Management	0.25%	7,964.00	<0.01%	+0	2026/06/30
UBS Asset Management AG	0.21%	6,550.00	0.02%	+790.00	2026/06/30
Alan SobelIndependent Director	0.20%	6,422.00	0.08%	+2,499.00	2026/09/15
Northern Trust Global Investments	0.18%	5,583.00	0.03%	+956.00	2026/06/30